HLA Hypersensitivity to Abacavir B*5701 Test sale cost 1400 AED
Immune Complex Detection by C1q Binding Test sale cost 1460 AED Immune Complex Detection by C1q Binding Test Cost 1,630 د.إ Original price was: 1,630 د.إ.1,460 د.إCurrent price is: 1,460 د.إ.
Vasculitis Panel Test sale cost 1400 AED Vasculitis Panel Test Cost 1,560 د.إ Original price was: 1,560 د.إ.1,400 د.إCurrent price is: 1,400 د.إ.
Sale!

HLA Hypersensitivity to Abacavir B*5701 Test Cost

Original price was: 1,560 د.إ.Current price is: 1,400 د.إ.

-10%

The HLA Hypersensitivity to Abacavir B*5701 Test is a genetic screening designed to identify individuals who are at risk of developing a hypersensitivity reaction to abacavir, a medication commonly used in the treatment of HIV. This hypersensitivity reaction can be severe and potentially life-threatening, making it crucial to identify at-risk individuals before the initiation of abacavir treatment.

The test specifically looks for the presence of the HLA-B*5701 allele, a genetic variant strongly associated with an increased risk of abacavir hypersensitivity. By detecting this allele, healthcare providers can make informed decisions regarding the suitability of abacavir for their patients, thus significantly reducing the risk of adverse reactions.

Offered at DNA Labs UAE, the HLA Hypersensitivity to Abacavir B*5701 Test is priced at 1400 AED. Conducted in a state-of-the-art laboratory setting, the test provides accurate and reliable results, ensuring that patients receive the safest and most effective care tailored to their genetic profile.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA Hypersensitivity to Abacavir B*5701 Test

At DNA Labs UAE, we offer the HLA Hypersensitivity to Abacavir B*5701 Test at a cost of AED 1400.0. This genetic test helps determine if an individual has a specific human leukocyte antigen (HLA) gene variant called HLA-B*57:01.

Test Components and Sample Condition

The test requires a sample of 4 mL (minimum 3 mL) whole blood in 1 Lavender Top (EDTA) tube or 6 mL (minimum 3 mL) whole blood in 1 Yellow Top (ACD) tube. Alternatively, a buccal swab collected in a sterile container can also be used. The sample should be shipped refrigerated and should not be frozen.

Report Delivery and Method

The report for the HLA Hypersensitivity to Abacavir B*5701 Test is typically delivered within 10-12 days. The test is performed using PCR (Polymerase Chain Reaction) sequencing method.

Test Type and Doctor

The HLA Hypersensitivity to Abacavir B*5701 Test falls under the category of AIDS tests. It is recommended to consult a physician for this test.

Pre Test Information

No special preparation is required before taking this test.

Test Details

The HLA Hypersensitivity to Abacavir (B*57:01) Test is crucial in identifying individuals who are at risk of developing a severe hypersensitivity reaction to the antiretroviral drug abacavir, which is commonly used to treat HIV infection. The test helps determine if an individual has the HLA-B*57:01 variant, which is associated with an increased risk of hypersensitivity reaction to abacavir.

Hypersensitivity reactions to abacavir can manifest as fever, rash, gastrointestinal symptoms, respiratory symptoms, and in severe cases, life-threatening conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. By identifying individuals with the HLA-B*57:01 variant, healthcare providers can avoid prescribing abacavir to these individuals and opt for alternative antiretroviral medications.

This test plays a crucial role in preventing severe hypersensitivity reactions and improving patient safety and treatment outcomes. It is typically performed using a blood sample, and the results can guide healthcare providers in making informed decisions regarding the use of abacavir in HIV treatment.

Test Name HLA HYPERSENSITIVITY TO ABACAVIR B*5701 Test
Components
Price 1400.0 AED
Sample Condition 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube OR Buccal swab collected in a sterile container. Ship refrigerated. DO NOT FREEZE.
Report Delivery 10-12 days
Method PCR, Sequencing
Test type AIDS
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The HLA hypersensitivity to abacavir (B*57:01) test is a genetic test that determines if an individual has a specific human leukocyte antigen (HLA) gene variant called HLA-B*57:01. This variant is associated with an increased risk of hypersensitivity reaction to the antiretroviral drug abacavir, which is used to treat HIV infection.

The test is usually performed before starting abacavir therapy to identify individuals who are at risk of developing a severe hypersensitivity reaction. This reaction can manifest as fever, rash, gastrointestinal symptoms, respiratory symptoms, and potentially life-threatening conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis.

By identifying individuals with the HLA-B*57:01 variant, healthcare providers can avoid prescribing abacavir to these individuals and opt for alternative antiretroviral medications. This test helps prevent severe hypersensitivity reactions and improves patient safety and treatment outcomes.

The test is typically performed using a blood sample, and the results can guide healthcare providers in making informed decisions regarding the use of abacavir in HIV treatment.

SKU: TEST-5411 Category:

Related products